Ranking of the main serotonin and norepinephrine reuptake inhibitors (SNRIs) in the United States in 2013, according to revenue
(in thousands of U.S. dollars)
Characteristic
Revenue in thousands of U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The chart is not accessible to screen readers. Please switch to the table view to access the data.
You need a ÌÇÐÄÆƽâ°æ Account for unlimited access
This statistic shows a ranking of the main serotonin and norepinephrine reuptake inhibitors (SNRIs) in the United States in 2013, according to revenue (in thousands of U.S. dollars). That year, Pristiq was among the top SNRIs generating revenue of *** million U.S. dollars in the United States. SNRIs are a type of antidepressant medication used to treat major depression or other mood disorders.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Drug Store News. (February 17, 2014). Ranking of the main serotonin and norepinephrine reuptake inhibitors (SNRIs) in the United States in 2013, according to revenue (in thousands of U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 03, 2026, from /statistics/1639065/top-irsns-in-the-united-states-based-on-revenue-in/
Drug Store News. "Ranking of the main serotonin and norepinephrine reuptake inhibitors (SNRIs) in the United States in 2013, according to revenue (in thousands of U.S. dollars)." Chart. February 17, 2014. ÌÇÐÄÆƽâ°æ. Accessed August 03, 2026. /statistics/1639065/top-irsns-in-the-united-states-based-on-revenue-in/
Drug Store News. (2014). Ranking of the main serotonin and norepinephrine reuptake inhibitors (SNRIs) in the United States in 2013, according to revenue (in thousands of U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 03, 2026. /statistics/1639065/top-irsns-in-the-united-states-based-on-revenue-in/
Drug Store News. "Ranking of The Main Serotonin and Norepinephrine Reuptake Inhibitors (Snris) in The United States in 2013, According to Revenue (in Thousands of U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Feb 2014, /statistics/1639065/top-irsns-in-the-united-states-based-on-revenue-in/
Drug Store News, Ranking of the main serotonin and norepinephrine reuptake inhibitors (SNRIs) in the United States in 2013, according to revenue (in thousands of U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1639065/top-irsns-in-the-united-states-based-on-revenue-in/ (last visited August 03, 2026)
Ranking of the main serotonin and norepinephrine reuptake inhibitors (SNRIs) in the United States in 2013, according to revenue (in thousands of U.S. dollars) [Graph], Drug Store News, February 17, 2014. [Online]. Available: /statistics/1639065/top-irsns-in-the-united-states-based-on-revenue-in/
